Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

BioStock: Abliva leads the fight against mitochondrial disease

Abliva

This week, mitochondrial disease is in focus during Mitochondrial Disease Week, highlighting a condition that, despite its often severe impact, remains relatively unknown. While research has progressed, there are still no approved treatments. Swedish biotech Abliva is at the forefront of changing this, with its phase II study of drug candidate KL1333 recently reaching a significant milestone.

Read the article about Abliva at biostock.se:
https://www.biostock.se/en/2024/09/abliva-leads-the-fight-against-mitochondrial-disease
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.